ICF International (NASDAQ:ICFI), a leading provider of consulting services and technology solutions to government and commercial clients, was recently awarded a re-compete task order with the Centers for Disease Control and Prevention (CDC) Division of HIV/AIDS Prevention (DHAP). The order was issued under the General Services Administration Professional Services Schedule. It has a value of $34.6 million and a term of five years, including one six-month base and nine six-month option periods.
"We are extremely proud of the contributions ICF has made in helping the country reach important milestones in HIV/AIDS prevention," said Mary Whitley, senior vice president for ICF International. "Though challenges remain, we remain deeply committed to continuing to help CDC measure the impact of this devastating disease and develop strategies and programs designed to further reduce the incidence of HIV infection."
For More Information
- ICF International
- ICF HIV Program Support and Expertise
- ICF Behavior and Disease Surveillance
- ICF Health Informatics and Systems
ICF (NASDAQ:ICFI) is a global consulting and technology services provider with more than 5,000 professionals focused on making big things possible for our clients. We are business analysts, policy specialists, technologists, researchers, digital strategists, social scientists and creatives. Since 1969, government and commercial clients have worked with ICF to overcome their toughest challenges on issues that matter profoundly to their success. Come engage with us at icf.com.
Fourth Quarter Highlights
- Total Revenue Increased 2 Percent to $281 Million, Led by Growth in U.S. Federal Government, State and Local Government and Domestic Commercial Revenue
- Non-GAAP EPS1 Was $0.73; Diluted EPS Was $0.55, Inclusive of $0.03 of Special Charges
Full Year 2015 Highlights
- Total Revenue Increased 8 Percent to $1.13 Billion; Service Revenue1 up 10 Percent
- Non-GAAP EPS Was $2.64; Diluted EPS Was $2.00, Inclusive of $0.10 of Special Charges
- Operating Cash Flow Was $76 Million, or $3.88 Per Diluted Share
- Contract Awards Reached a Record $1.3 Billion; Book-to-Bill Ratio of 1.17